Jafron Biomedical Co.,Ltd. (SHE:300529)
18.71
-0.27 (-1.42%)
At close: Mar 9, 2026
-25.84% (1Y)
| Market Cap | 14.49B |
| Revenue (ttm) | 2.04B |
| Net Income (ttm) | 481.79M |
| Shares Out | 774.36M |
| EPS (ttm) | 0.63 |
| PE Ratio | 29.72 |
| Forward PE | 26.45 |
| Dividend | 0.80 (4.21%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 5,212,316 |
| Average Volume | 4,556,583 |
| Open | 18.90 |
| Previous Close | 18.98 |
| Day's Range | 18.52 - 18.90 |
| 52-Week Range | 18.52 - 27.21 |
| Beta | 0.43 |
| RSI | 30.68 |
| Earnings Date | Apr 28, 2026 |